[go: up one dir, main page]

PT1114641E - Composicoes de fluoroeter e metodos para inibicao da sua degradacao na presenca de um acido de lewis - Google Patents

Composicoes de fluoroeter e metodos para inibicao da sua degradacao na presenca de um acido de lewis

Info

Publication number
PT1114641E
PT1114641E PT01107733T PT01107733T PT1114641E PT 1114641 E PT1114641 E PT 1114641E PT 01107733 T PT01107733 T PT 01107733T PT 01107733 T PT01107733 T PT 01107733T PT 1114641 E PT1114641 E PT 1114641E
Authority
PT
Portugal
Prior art keywords
lewis acid
fluoroeter
inhibiting
degradation
compositions
Prior art date
Application number
PT01107733T
Other languages
English (en)
Inventor
Christopher Bieniarz
Steve H Chang
Keith R Cromack
Shuyen L Huang
Toshikazu Kawai
Manami Kobayashi
David Loffredo
Rajagopalan Raghavan
Earl R Speicher
Honorate A Stelmach
Original Assignee
Abbott Lab
Central Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25148366&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1114641(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab, Central Glass Co Ltd filed Critical Abbott Lab
Publication of PT1114641E publication Critical patent/PT1114641E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Catalysts (AREA)
  • Steroid Compounds (AREA)
PT01107733T 1997-01-27 1998-01-23 Composicoes de fluoroeter e metodos para inibicao da sua degradacao na presenca de um acido de lewis PT1114641E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/789,679 US5990176A (en) 1997-01-27 1997-01-27 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid

Publications (1)

Publication Number Publication Date
PT1114641E true PT1114641E (pt) 2006-05-31

Family

ID=25148366

Family Applications (2)

Application Number Title Priority Date Filing Date
PT98902707T PT967975E (pt) 1997-01-27 1998-01-23 Composicoes de fluoroeter e metodos para a inibicao da sua degradacao na presenca de um acido de lewis
PT01107733T PT1114641E (pt) 1997-01-27 1998-01-23 Composicoes de fluoroeter e metodos para inibicao da sua degradacao na presenca de um acido de lewis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT98902707T PT967975E (pt) 1997-01-27 1998-01-23 Composicoes de fluoroeter e metodos para a inibicao da sua degradacao na presenca de um acido de lewis

Country Status (27)

Country Link
US (6) US5990176A (pt)
EP (2) EP0967975B1 (pt)
JP (5) JP3183520B2 (pt)
KR (1) KR100368672B1 (pt)
CN (3) CN1152674C (pt)
AR (2) AR011090A1 (pt)
AT (2) ATE320798T1 (pt)
AU (1) AU726733B2 (pt)
BG (2) BG109751A (pt)
BR (1) BR9806996A (pt)
CA (2) CA2278133C (pt)
CO (1) CO4920220A1 (pt)
CZ (1) CZ297092B6 (pt)
DE (2) DE69833884T2 (pt)
DK (2) DK0967975T3 (pt)
ES (2) ES2170474T3 (pt)
GR (1) GR3036190T3 (pt)
HU (1) HUP0002101A3 (pt)
IL (1) IL130150A (pt)
NO (1) NO993606L (pt)
NZ (1) NZ335994A (pt)
PL (1) PL334477A1 (pt)
PT (2) PT967975E (pt)
SK (1) SK284243B6 (pt)
TR (1) TR199901579T2 (pt)
WO (1) WO1998032430A1 (pt)
ZA (1) ZA98418B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990176A (en) * 1997-01-27 1999-11-23 Abbott Laboratories Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
US6074668A (en) * 1998-01-09 2000-06-13 Abbott Laboratories Container for an inhalation anesthetic
US6162443A (en) * 1998-01-09 2000-12-19 Abbott Laboratories Container for an inhalation anesthetic
US20030200963A1 (en) * 1998-01-09 2003-10-30 Flament-Garcia Mary Jane Container for an inhalation anesthetic
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
EP1105096B1 (en) 1998-08-19 2003-10-29 Skyepharma Canada Inc. Injectable aqueous dispersions of propofol
EP1530336B1 (en) 1999-01-08 2009-06-10 Sony Deutschland GmbH Synchronization preamble structure for OFDM system
TW523409B (en) 2000-09-15 2003-03-11 Baxter Int Container for inhalation anesthetic
BR0303489A (pt) * 2003-09-10 2005-07-05 Cristalia Prod Quimicos Farm Composição farmacêutica estabilizada de composto flúor-éter e método para inibir a degradação de composto flúor-éter. uso de agente estabilizante para inibir a degradação de composto flúor éter
US7816409B2 (en) * 2003-09-10 2010-10-19 Cristalia Productos Quimicos Farmaceuticos Ltda Stable pharmaceutical composition of fluoroether compound for anesthetic use method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
EP1871734A4 (en) * 2005-04-18 2010-08-04 Piramal Critical Care Inc PREPARATION OF SEVOFLURAN WITH LOW WATER CONTENT
WO2009049460A1 (en) * 2007-10-15 2009-04-23 Jiangsu Hengrui Medicine Co., Ltd. New packaging material for sevoflurane
CN107661293A (zh) * 2008-01-22 2018-02-06 得克萨斯大学体系董事会 用于局部麻醉和/或疼痛缓解的含有萃取溶剂的挥发性麻醉剂组合物
US20090275785A1 (en) * 2008-05-01 2009-11-05 Barry Jones Distillation Method For The Purification Of Sevoflurane And The Maintenance Of Certain Equipment That May Be Used In The Distillation Process
US8563115B2 (en) 2008-08-12 2013-10-22 Xerox Corporation Protective coatings for solid inkjet applications
US8092822B2 (en) * 2008-09-29 2012-01-10 Abbott Cardiovascular Systems Inc. Coatings including dexamethasone derivatives and analogs and olimus drugs
US8283643B2 (en) * 2008-11-24 2012-10-09 Cymer, Inc. Systems and methods for drive laser beam delivery in an EUV light source
US8191992B2 (en) * 2008-12-15 2012-06-05 Xerox Corporation Protective coatings for solid inkjet applications
US9278048B2 (en) * 2009-05-06 2016-03-08 Baxter International, Inc. Pharmaceutical product and method of use
US9102604B1 (en) 2010-02-15 2015-08-11 Baxter International Inc. Methods for cleaning distilling columns
CN105193774B (zh) * 2015-09-21 2018-01-16 山东新时代药业有限公司 一种七氟烷吸入剂
CN105106182B (zh) * 2015-09-21 2017-12-29 山东新时代药业有限公司 七氟烷吸入剂
BE1024432B1 (fr) * 2016-11-02 2018-02-19 Central Glass Company, Limited Procédé pour le lavage de récipient de stockage de sévoflurane et procédé pour le stockage de sévoflurane

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2992276A (en) * 1959-05-20 1961-07-11 Du Pont Process for preparing polyfluoro alkyl compounds
US3527813A (en) * 1966-10-03 1970-09-08 Air Reduction 1,1,2 - trifluoro - 2 - chloroethyl difluoromethyl ether and its method of preparation
US3689571A (en) * 1970-07-31 1972-09-05 Baxter Laboratories Inc Fluorinated ether
GB1499818A (en) * 1974-12-06 1978-02-01 Ici Ltd Anaesthetic composition
US4250334A (en) * 1979-12-26 1981-02-10 Baxter Travenol Laboratories, Inc. Method of synthesizing fluoromethylhexafluoroisopropyl ether
US4469898A (en) * 1979-12-26 1984-09-04 Baxter Travenol Laboratories, Inc. Method of synthesizing fluoromethylhexafluoroisopropyl ether
JP2786108B2 (ja) * 1994-03-31 1998-08-13 セントラル硝子株式会社 フルオロメチル−１，１，１，３，３，３−ヘキサフルオロイソプロピルエーテルの精製方法
IT1270239B (it) * 1994-06-17 1997-04-29 Zambon Spa Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
US5990176A (en) * 1997-01-27 1999-11-23 Abbott Laboratories Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid

Also Published As

Publication number Publication date
US5990176A (en) 1999-11-23
BG109751A (bg) 2008-06-30
JP2001187729A (ja) 2001-07-10
EP1114641A3 (en) 2003-05-28
EP0967975A1 (en) 2000-01-05
CO4920220A1 (es) 2000-05-29
EP1114641B1 (en) 2006-03-22
NO993606L (no) 1999-09-24
ES2256104T3 (es) 2006-07-16
BG103656A (en) 2000-04-28
WO1998032430A1 (en) 1998-07-30
KR20000070482A (ko) 2000-11-25
US6444859B2 (en) 2002-09-03
EP1114641A2 (en) 2001-07-11
CN1244797A (zh) 2000-02-16
HUP0002101A2 (hu) 2001-05-28
PT967975E (pt) 2001-11-30
CN1152674C (zh) 2004-06-09
ZA98418B (en) 1999-04-20
CA2278133A1 (en) 1998-07-30
SK86199A3 (en) 2000-06-12
HK1074434A1 (en) 2005-11-11
IL130150A (en) 2004-09-27
DE69800928T2 (de) 2001-11-22
CA2626424A1 (en) 1998-07-30
DK1114641T3 (da) 2006-05-15
GR3036190T3 (en) 2001-10-31
CN1899271A (zh) 2007-01-24
ATE201987T1 (de) 2001-06-15
JP2006143742A (ja) 2006-06-08
TR199901579T2 (xx) 1999-12-21
DE69800928D1 (de) 2001-07-19
DK0967975T3 (da) 2001-09-17
SK284243B6 (sk) 2004-12-01
AR057610A2 (es) 2007-12-05
JP3664648B2 (ja) 2005-06-29
US20020016373A1 (en) 2002-02-07
KR100368672B1 (ko) 2003-01-24
DE69833884T2 (de) 2006-08-24
CZ297092B6 (cs) 2006-09-13
EP0967975B1 (en) 2001-06-13
IL130150A0 (en) 2001-03-19
BG65414B1 (bg) 2008-07-31
US20060148906A1 (en) 2006-07-06
AU726733B2 (en) 2000-11-16
PL334477A1 (en) 2000-02-28
BR9806996A (pt) 2000-03-14
ATE320798T1 (de) 2006-04-15
US20040048932A1 (en) 2004-03-11
AU5930098A (en) 1998-08-18
AR011090A1 (es) 2000-08-02
JP2000510159A (ja) 2000-08-08
JP2006137769A (ja) 2006-06-01
CN1560003A (zh) 2005-01-05
US6677492B2 (en) 2004-01-13
HUP0002101A3 (en) 2002-03-28
CA2278133C (en) 2001-06-26
JP3183520B2 (ja) 2001-07-09
NO993606D0 (no) 1999-07-23
NZ335994A (en) 2000-08-25
CN1321958C (zh) 2007-06-20
CZ256199A3 (cs) 1999-11-17
US20030130359A1 (en) 2003-07-10
ES2170474T3 (es) 2002-08-01
US6288127B1 (en) 2001-09-11
DE69833884D1 (de) 2006-05-11
JP2005279283A (ja) 2005-10-13

Similar Documents

Publication Publication Date Title
PT1114641E (pt) Composicoes de fluoroeter e metodos para inibicao da sua degradacao na presenca de um acido de lewis
BR9912073A (pt) Composições farmacêuticas que compreendem 2-quinolonas
CO4970765A1 (es) Composiciones de bajo ph que contienen acido para el cuidado personal que exhiben picazon reducida
ATE202337T1 (de) Cyclopropylalkansäurederivate
MX9202166A (es) Derivados de amidino fenil alanina, procedimiento para su preparacion su empleo y agentes que los con tienen en calidad de anticoagulantes.
NO991494L (no) <beta>-sulfonylhydroksaminsyrer som matriksmetalloproteinaseinhibitorer
ES2128519T3 (es) Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2120145T3 (es) Compuestos bi-aromaticos acetilenados con grupo adamantilo, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
NO983530D0 (no) Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler
DE69702182D1 (de) Alkylierte styrole als prodrugs zu cox-2-inhibitoren
NO20022977D0 (no) Substituerte homopiperidinylbenzimidazolanaloger som fundiske relaksanter
MX9300840A (es) Compuestos farmaceuticos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
NZ326283A (en) Diphenyl stilbenes as prodrugs to cox-2 inhibitors
ZA951013B (en) Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
EA199900479A1 (ru) Стабилизированные фармацевтические композиции на основе хинупристина и дальфопристина и способ получения
NO20013499L (no) Farmasoytisk blanding omfattende en kombinasjon av en profen og andre aktive forbindelser
MX9302429A (es) Nuevas tetralonas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
ES2149247T3 (es) Nuevos compuestos de n-bencil-piperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los incluyen.
IT1299544B1 (it) Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine
ES2118340T3 (es) Nuevos derivados de benzo-espiro-alquenos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2103553T3 (es) Nuevos cicloalquil-(b)-indoles, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2105569T3 (es) Nuevos analogos de metabolitos de acidos grasos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
UA19195A (uk) Фотополімеризаційhа композиція
IT1265045B1 (it) Composizione farmaceutica atta a inibire la sintesi della lipoproteina (a)
SE8803932D0 (sv) New octahydro indenofuran derivatives, their preparation and therapeutic composition containing the same